Oncology

Renal cell carcinoma (RCC) is the most common primary tumour originating from the kidney, and accounts for more than 90% of all renal…

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…

Endometrial cancer is the most common gynaecologic malignancy in high-income countries due to increased life expectancy. Approximately…

Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…

Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…

This paper explores the overlooked influence of food insecurity on cancer care, its correlation with malnutrition and poor patient…

Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and often presents with comorbidities…